Results 221 to 230 of about 24,427,288 (283)
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
Roadmap for inferring metabolic regulation using multiomics, machine learning, and genome-scale modeling. [PDF]
Schildcrout R +2 more
europepmc +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
Evaluation of replication success: A statistical perspective and extended analysis of the SCORE data. [PDF]
van Aert RCM +2 more
europepmc +1 more source
Assessing EHR Cohort Fitness With Partially Paired Registry Data: A New Statistical Approach Applied to Maternal Health in OneFlorida. [PDF]
Harrall KK +5 more
europepmc +1 more source
Ability of clinical assessment methods to differentiate levels of competence in undergraduate nursing education: a scoping review protocol. [PDF]
AlMekkawi M +3 more
europepmc +1 more source

